An animal study conducted by New York University researchers suggests that partially inhibiting an enzyme that initiates the release of amyloid beta may help improve memory dysfunction.
This could be real good news for Alzheimer's patients. New York University researchers, after a successful animal study, suggest that partially inhibiting an enzyme that initiates the release of amyloid beta may help improve memory dysfunction.
Lead researcher Dr. Masuo Ohno, an expert at the Center for Dementia Research at the Nathan Kline Institute, has revealed that this proposition is based on the results of a study on mice.
Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Based on their observations, the researchers came to the conclusion that the approach showed a possibility to rescue Alzheimer's-related deficits.
A presentation on the study was made at the ongoing Alzheimer's Association 2008 International Conference, which runs until July 31 in Chicago.
Brilliant Human Brain
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
The most amazing and complex organ in the entire universe, the human brain continues to remain an enigma.
TAN/M
Want To Retain Your Memory? Believe That You Can Do So!
The first step to retaining a good memory as we age is to believe that it is possible do so.
The first step to retaining a good memory as we age is to believe that it is possible do so.
Amyloid Plays an Important Role in Memory
Scientists at NYU Langone Medical Center have discovered that the beta amyloid peptide - which accumulates in brain plaques in people with Alzheimer's disease - not only plays a role
Scientists at NYU Langone Medical Center have discovered that the beta amyloid peptide - which accumulates in brain plaques in people with Alzheimer's disease - not only plays a role
